Quantbot Technologies LP Omeros Corp Transaction History

Quantbot Technologies LP

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$2.81 - $5.69 $2,596 - $5,257	924 Added 47.85%	2,855 $8,000
Q2 2023 Aug 08, 2023	BUY	$4.45 - $7.57 $8,592 - $14,617	1,931 New	1,931 $10,000
Q4 2022 Feb 13, 2023	BUY	$1.75 - $3.96 $21,332 - $48,272	12,190 New	12,190 $27,000
Q2 2022 Aug 09, 2022	SELL	$1.92 - $6.28 $8,382 - $27,418	-4,366 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.07 - $7.2 $61,199 - $86,911	-12,071 Reduced 73.44%	4,366 $26,000
Q4 2021 Feb 11, 2022	BUY	$5.67 - $8.54 $93,197 - $140,371	16,437 New	16,437 $105,000
Q3 2021 Nov 09, 2021	SELL	$13.4 - $16.3 $138,931 - $168,998	-10,368 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$14.81 - $19.13 $78,344 - $101,197	5,290 Added 104.17%	10,368 $153,000
Q1 2021 May 14, 2021	BUY	$14.52 - $23.53 $57,818 - $93,696	3,982 Added 363.32%	5,078 $90,000
Q4 2020 Feb 12, 2021	SELL	$10.14 - $15.19 $31,068 - $46,542	-3,064 Reduced 73.65%	1,096 $15,000
Q3 2020 Nov 16, 2020	BUY	$9.57 - $21.32 $39,811 - $88,691	4,160 New	4,160 $42,000
Q1 2020 May 13, 2020	SELL	$9.03 - $19.72 $902 - $1,972	-100 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$13.01 - $17.15 $1,301 - $1,714	100 New	100 $1,000
Q1 2019 May 13, 2019	SELL	$11.65 - $17.72 $113,529 - $172,681	-9,745 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$10.72 - $16.73 $104,466 - $163,033	9,745 New	9,745 $108,000
Q2 2018 Aug 13, 2018	SELL	$10.79 - $24.44 $52,568 - $119,071	-4,872 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$9.0 - $20.16 $50,607 - $113,359	-5,623 Reduced 53.58%	4,872 $54,000
Q4 2017 Feb 12, 2018	BUY	$13.26 - $22.86 $139,163 - $239,915	10,495	10,495 $203,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $712M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.